The HLA-DQA1*05 allele is carried by 20%-40% of Europeans and has been strongly associated with autoimmune disorders, including celiac disease and inflammatory bowel diseases, whereas it has also been reported that the carriers tend to develop antibodies against infliximab [19]. Here, HLA-DQA1 is linked to inflammatory bowel disease.